Controlled Myelofibrosis Study with Oral JAK Inhibitor Treatment

Receive Updates from Incyte

If you would like to receive periodic updates about the COMFORT clinical trials, disease information, or product information please fill in the fields below. An (*) indicates a required field.

*First name
*Last name
Designation
Profession/Specialty
	Other:
*E-mail
Are you interested in learning more about future clinical trials?	YesNo
Please estimate the number of patients you typically see in a year with the following diseases:
Polycythemia vera:
Essential thrombocythemia:
Myelofibrosis:
Do you mainly work in a private practice, hospital, or academic setting?	PrivateHospitalAcademic
Please enter the city, state/province, and country where you practice.

..........................................................................................................................................................................................................................................................................................................................

This is an international Web site for the COMFORT-I and COMFORT-II trials. The information on this site is not country-specific and may contain trial information that is different from where you practice. INCB018424 is investigational. Efficacy and safety have not been established. There is no guarantee that this compound will become commercially available.